Japan Medical Dynamic Marketing, INC.
Stock Price Chart
2026/07/30 UpdatedPrice Trend
2026/07/30 UpdatedPrice & Trading Details
2026/07/30 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/07/01Major Holders
Updated 2026/07/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.
|
57.4K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
36.9K | -26.47% | |
|
Dimensional ETF Trust-Dimensional International Small Cap Value ETF
|
27.6K | +24.93% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
26.3K | +3.11% | |
|
Dimensional ETF Trust-Dimensional International Core Equity 2 ETF
|
25.1K | 0.00% | |
|
Dimensional ETF Trust-Dimensional International Small Cap ETF
|
24.2K | 0.00% |
Dividend History 4Years Growth
Updated 2026/07/26| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥17 | +13.3% |
| 2025 | ¥15 | +7.1% |
| 2024 | ¥14 | +7.7% |
| 2023 | ¥13 | +8.3% |
| 2022 | ¥12 | - |
Financial Performance
2026/07/26 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥21,308M | ¥23,178M | ¥25,114M | ¥23,917M |
| Gross Profit | ¥13,993M | ¥14,762M | ¥15,647M | ¥14,142M |
| Operating Income | ¥2,025M | ¥1,747M | ¥1,556M | ¥574M |
| Pretax Income | ¥1,788M | ¥1,669M | -¥267M | ¥694M |
| Net Income | ¥1,424M | ¥1,272M | -¥462M | ¥263M |
| EPS | ¥54.03 | ¥48.31 | -¥17.50 | ¥9.99 |
| Operating Margin | 9.50% | 7.54% | 6.20% | 2.40% |
| Balance Sheet | ||||
| Total Assets | ¥29,435M | ¥31,486M | ¥33,667M | ¥35,679M |
| Total Equity | ¥23,162M | ¥25,511M | ¥24,679M | ¥25,400M |
| Total Liabilities | ¥6,273M | ¥5,975M | ¥8,988M | ¥10,279M |
| Cash | ¥2,805M | ¥2,322M | ¥3,182M | ¥3,107M |
| Interest-bearing Debt | ¥1,872M | ¥1,494M | ¥3,287M | ¥5,871M |
| Equity Ratio | 78.69% | 81.02% | 73.30% | 71.19% |
| D/E Ratio | 0.08 | 0.06 | 0.13 | 0.23 |
| Cash Flow | ||||
| Operating CF | ¥2,186M | ¥2,105M | ¥1,047M | ¥206M |
| Investing CF | -¥1,482M | -¥1,805M | -¥1,667M | -¥1,996M |
| Financing CF | -¥515M | -¥841M | ¥1,490M | ¥1,649M |
| Free CF | ¥871M | ¥302M | -¥620M | -¥1,792M |
| Efficiency | ||||
| ROE | 6.15% | 4.98% | -1.87% | 1.04% |
| ROA | 4.84% | 4.04% | -1.37% | 0.74% |
Latest IR Information
-
Q1 FY2027 Financial Results Summary | Net Sales of ¥532.5 billion (Up 15.7% YoY)
Japan M.D.M. achieved net sales of ¥532.5 billion (up 15.7% YoY) in the first quarter of FY2027, maintaining strong performance primarily in the Medical Devices segment. Both revenue and profit increased compared to the same period last year.
Read more -
Matters Related to Principal Shareholders, etc.
Read more
Latest News (5 items)
Company Information
About
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices to fix spinal instability directly through corrective surgery; and artificial bones that are used to fill gaps in bone defects caused by bone fractures or bone tumors. It offers its products to doctors and hospitals. The company was incorporated in 1973 and is headquartered in Shinjuku, Japan.
